Pretreatment resistin levels are associated with erosive disease in early rheumatoid arthritis treated with disease-modifying anti-rheumatic drugs and infliximab
Authors:
- K VuolteenahoKVK Vuolteenaho
- NEO-RACo Study GroupNGNEO-RACo Study Group
Open Access
- 15 July 2021
- journal article
- research article
- Published by Taylor & Francis in Scandinavian Journal of Rheumatology
- Vol. 51 (3) , 180-185
Abstract
Resistin is an adipocytokine related to insulin resistance and inflammation. We investigated whether resistin is associated with disease activity and inflammation in disease-modifying anti-rheumati...Keywords
Funding Information
- Scandinavian Rheumatology Research Foundation
- Maire Lisko Foundation
- Schering-Plough Finland
- Competitive Research Funding of the Tampere University Hospital
- Helsinki University Central Hospital Research Funds
This publication has 19 references indexed in Scilit:
- Resistin in metabolism, inflammation, and diseaseThe FEBS Journal, 2020
- The Adipokine Network in Rheumatic Joint DiseasesInternational Journal of Molecular Sciences, 2019
- Serum resistin levels in patients with rheumatoid arthritis and systemic lupus erythematosus: a meta-analysisClinical Rheumatology, 2015
- Targeted treatment with a combination of traditional DMARDs produces excellent clinical and radiographic long-term outcomes in early rheumatoid arthritis regardless of initial infliximab. The 5-year follow-up results of a randomised clinical trial, the NEO-RACo trialAnnals of the Rheumatic Diseases, 2014
- Failure in Longterm Treatment is Rare in Actively Treated Patients with Rheumatoid Arthritis, But May Be Predicted by High Health Assessment Score at Baseline and by Residual Disease Activity at 3 and 6 Months: The 5-year Followup Results of the Randomized Clinical NEO-RACo TrialThe Journal of Rheumatology, 2014
- Adenylyl Cyclase-Associated Protein 1 Is a Receptor for Human Resistin and Mediates Inflammatory Actions of Human MonocytesCell Metabolism, 2014
- Infliximab for 6 months added on combination therapy in early rheumatoid arthritis: 2-year results from an investigator-initiated, randomised, double-blind, placebo-controlled study (the NEO-RACo Study)Annals of the Rheumatic Diseases, 2013
- Classification accuracy and cut point selectionStatistics in Medicine, 2012
- Resistin is linked to inflammation, and leptin to metabolic syndrome, in women with inflammatory arthritisScandinavian Journal of Rheumatology, 2011
- Modified disease activity scores that include twenty-eight-joint counts development and validation in a prospective longitudinal study of patients with rheumatoid arthritisArthritis & Rheumatism, 1995